After an 80-year gap, human trials of a new tuberculosis vaccine are due to
start. If the vaccine is successful it could save millions of lives each year.
TB jabs use a weakened form of the bacterium that causes the disease in
cows—Bacille Calmette-Guérin. BCG gives good protection for about
10 years but then it wears off, and booster shots have little effect. Now Helen
McShane at the John Radcliffe Hospital in Oxford is starting trials with a
modified cowpox virus that carries a TB antigen. Used as a booster after BCG,
the new vaccine should give a…
To continue reading, today with our introductory offers
Advertisement
More from Â鶹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ã½ articles
1
We've found a mysterious substance on Titan and Pluto
2
Faecal transplant makes the brains of old mice act young again
3
Most portable air conditioners suck – but there's an easy fix
4
Has the answer to life's origins been hiding in our cells all along?
5
A quantum state that lasts forever may finally be within our grasp
6
Remarkable fossils rewrite the story of how animals conquered the land
7
Walking shark found in Papua New Guinea is new to science
8
Our brains have their first thoughts surprisingly early in life
9
Fully autonomous drones have killed human soldiers for the first time
10
Arctic Ocean reaches tipping point that could be dire for marine life
